Delivery Order SPE2DB20D1100-SPE2DB25FD1X8
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,381.10 fixed-price delivery order is for the supply of 4,568,423,956 vials of the drug XEOMIN 100 UNIT. The contract has a period of performance through June 18, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.48 firm fixed price delivery order is for the supply of 4,568,252,858 vials of the medication XEOMIN 100 UNIT. The contract has an ultimate completion date of June 4, 2025 and was awarded on May 13, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,174.80, is a delivery order for 4,567,960,815 units of the pharmaceutical product XEOMIN 200 UNIT VIALS. The contract is a firm fixed-price, non-set-aside arrangement with a performance period through May 8, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,352.44 firm fixed-price delivery order is for the supply of 4,568,455,585 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The contract has an ultimate completion date of June 26, 2025 and is not set aside for any specific business designation. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,420.50 firm-fixed-price delivery order is for the supply of 4,568,252,863 units of the medication XEOMIN 100 UNIT VIALS. The contract has an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price of $13,968.50 and a completion date of July 16, 2025. The contract is for the supply of XEOMIN 100 unit vials and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $13,106 for the supply of 4,566,202,222 vials of the medication XEOMIN. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. The contract is a firm fixed-price delivery order that runs through November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a $2,234.96 Firm Fixed Price delivery order for 4,568,327,665 units of the medication XEOMIN 100 UNIT VIALS. The contract has a completion date of June 12, 2025 and was awarded on May 21, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,039.40 firm-fixed-price delivery order is for the supply of 50-unit vials of the pharmaceutical product XEOMIN. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $5,587.40 firm fixed-price delivery order is for 4,568,523,816 units of the medication XEOMIN 100. The contract has a completion date of July 3, 2025 and is not set aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which allows the company to supply a wide range...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD1X8Delivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $33,524.40 firm fixed-price delivery order is for the supply of 4,568,705,363 vials of the medication XEOMIN 100 UNIT. The contract has an ultimate completion date of July 23, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $33.5k | 7/1/25 |